Changes in serum tumour necrosis factor-α in burned patients

Burns

Volumn 23, Issue 1, 1997, Pages 6-10

  Yeh, Fa Lai ^a   Lin, W L ^b   Shen, H D ^b   Fang, R H ^b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIAL INFECTION; BLOOD LEVEL; BODY SURFACE; BURN; CLINICAL ARTICLE; FEMALE; HUMAN; IMMUNE RESPONSE; MALE; SEPSIS; TISSUE INJURY;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; BURNS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INJURY SEVERITY SCORE; MALE; MIDDLE AGED; PROGNOSIS; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031036472     PISSN: 03054179     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0305-4179(96)00071-X     Document Type: Article

References (27)

1. Youn YK, LaLonde C, Demling R. The role of mediators in the response to thermal injury. World J Surg 1992; 16: 30-36.
2. Drost AC, Burleson DG, Cioffi WG, Jordan BS, Mason AD, Pruitt BA. Plasma cytokines following thermal injury and their relationship with patient mortality, burn size, and time postburn. J Trauma 1993; 35: 335-339.
3. Drost AC, Burleson DG, Cioffi WG, Mason AD, Pruitt BA. Plasma cytokines after thermal injury and their relationship to infection. Ann Surg 1993; 218: 74-78.
4. De Bandt JP, Chollet-Martin S, Hernvann A et al. Cytokine response to burn injury: relationship with protein metabolism. J Trauma 1994; 36: 624-628.
5. Montegut W, Lowry SF, Moldawer LL. Role of cytokines in septic shock and shock-related syndromes. In: Aggarwal BB, Puri RK, eds. Human Cytokines: their role in disease and therapy. Cambridge, MA: Blackwell Science, 1995; pp 381-389.
6. Tracey KJ, Beutler B, Lowry SF et al. Shock and tissue injury induced by recombinant human cachectin. Science 1986; 234: 470-474.
7. Beutler B, Cerami A. Cachectin: more than a tumor necrosis factor. N Engl J Med 1987; 316: 379-385.
8. Richards CD, Gauldie J. Role of cytokines in acute-phase response. In: Aggarwal BB, Puri RK, eds. Human Cytokines: their role in disease and therapy. Cambridge, MA: Blackwell Science, 1995; pp 253-269.
9. Muraguchi A, Hirano T, Tang B et al. The essential role of B cell stimulatory factor 2 (BSF-2/IL-6) for the terminal differentiation of B cells. J Exp Med 1988; 167: 332-344.
10. Gauldie J, Richards C, Harnish D, Lansdorp P, Baumann H. Interferon β2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells. Proc Natl Acad Sci USA 1987; 84: 7251-7255.
11. Helle M, Brakenhoff JPJ, De Groot ER, Aarden LA. Interleukin-6 is involved in interleukin 1-induced activities. Eur J Immunol 1988; 18: 957-959.
12. Takai Y, Wong GG, Clark SC, Burakoff SJ, Herrmann SH. B cell stimulatory factor-2 is involved in the differentiation of cytotoxic T lymphocytes. J Immunol 1988; 140: 508-512.
13. Carswell EA, Old LJ, Kassel RL, Green S, Fiore N, Williamson B. An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci USA 1975; 72: 3666-3670.
14. Beutler B, Krochin N, Milsark IW, Luedke C, Cerami A. Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance. Science 1986; 232: 977-980.
15. Waage A, Halstensen A, Espevik T. Association between tumor necrosis factor in serum and fatal outcome in patients with meningococcal disease. Lancet 1987; i: 355-357.
16. Tracey KJ, Lowry SF, Fahey III TJ et al. Cachectin/tumor necrosis factor induces lethal shock and stress hormone responses in the dog. Surg Gynecol Obstet 1987; 164: 415-422.
17. van der Poll T, Buller HR, ten Cate H et al. Activation of coagulation after administration of tumor necrosis factor to normal subjects. N Engl J Med 1990; 322: 1622-1627.
18. Dinarello CA, Cannon JG, Wolff SM et al. Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1. J Exp Med 1986; 163: 1433-1450.
19. Marano MA, Fong Y, Moldawer LL et al. Serum cachectin/tumor necrosis factor in critically ill patients with burns correlates with infection and mortality. Surg Gynecol Obstet 1990; 170: 32-38.
20. Liu XS, Luo ZH, Yang ZC, Huang WH, Li AN. The significance of changes in serum tumor necrosis factor (TNF) activity in severely burned patients. Burns 1994; 20: 40-44.
21. Cannon JG, Tompkins RG, Gelfand JA et al. Circulating interleukin-1 and tumor necrosis factor in septic shock and experimental endotoxin fever. J Infect Dis 1990; 161: 79-84.
22. Offner F, Philippe J, Vogelaers D et al. Serum tumor necrosis factor levels in patients with infectious disease and septic shock. J Lab Clin Med 1990; 116: 100-105.
23. Fong Y, Moldawer LL, Shires GT, Lowry SF. The biologic characteristics of cytokines and their implication in surgical injury. Surg Gynecol Obstet 1990; 170: 363-378.
24. Endo S, Inada K, Yamada Y et al. Plasma tumor necrosis factor-α (TNF-α) levels in patients with burns. Burns 1993; 19: 124-127.
25. Beutler BA, Milsark IW, Cerami A. Cachectin/tumor necrosis factor: production, distribution, and metabolic fate in vivo. J Immunol 1985; 135: 3972-3977.
26. Liu XS, Yang ZC, Luo ZH, Huang WH, Li AN. A preliminary exploration of the relationship between tumor necrosis factor (TNF) and monocytic in vitro production of interleukin-1 (IL-1) and internal organ dysfunction in severely burned patients. Burns 1995; 21: 29-33.
27. Lesslauer W, Tabuchi H, Gentz R et al. Recombinant soluble tumor necrosis factor receptor proteins protect mice from lipopolysaccharide-induced lethality. Eur J Immunol 1991; 21: 2883-2886.